Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 20 | 4 | UROLOGY & NEPHROLOGY//GASTROENTEROLOGY & HEPATOLOGY//UROL | 479829 |
| 407 | 3 | BLADDER CANCER//CYSTECTOMY//UROLOGY & NEPHROLOGY | 30992 |
| 447 | 2 | BLADDER CANCER//BLADDER NEOPLASMS//UROTHELIAL CARCINOMA | 16396 |
| 33767 | 1 | ADENOVIRAL MEDIATED INTERFERON ALPHA//ADENOVIRAL MEDIATED INTERFERON ALPHA TREATMENT//ORTHOTOPIC BLADDER CANCER MODEL | 134 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ADENOVIRAL MEDIATED INTERFERON ALPHA | authKW | 940806 | 3% | 100% | 4 |
| 2 | ADENOVIRAL MEDIATED INTERFERON ALPHA TREATMENT | authKW | 470403 | 1% | 100% | 2 |
| 3 | ORTHOTOPIC BLADDER CANCER MODEL | authKW | 470403 | 1% | 100% | 2 |
| 4 | UNIT 0018 5 | address | 470403 | 1% | 100% | 2 |
| 5 | 13 17 BIS1 CARBOXYPROPIONCARBAMOYLETHYL 3 ETHENYL 8 ETHOXYIMINOETHYLIDENE 7 HYDROXY 2 7 12 18 TETRAMETHYL POR | authKW | 235202 | 1% | 100% | 1 |
| 6 | 65 KDA ANTIGEN | authKW | 235202 | 1% | 100% | 1 |
| 7 | ABERRANTLY GLYCOSYLATED INTEGRIN A3B1 | authKW | 235202 | 1% | 100% | 1 |
| 8 | ABSL 3 | authKW | 235202 | 1% | 100% | 1 |
| 9 | ADENOVIRAL MEDIATED INTERFERON ALPHA CELL DEATH | authKW | 235202 | 1% | 100% | 1 |
| 10 | ANALYT DEV N AMER | address | 235202 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Urology & Nephrology | 2113 | 37% | 0% | 49 |
| 2 | Oncology | 728 | 39% | 0% | 52 |
| 3 | Medicine, Research & Experimental | 254 | 17% | 0% | 23 |
| 4 | Genetics & Heredity | 184 | 16% | 0% | 22 |
| 5 | Biotechnology & Applied Microbiology | 176 | 16% | 0% | 22 |
| 6 | Immunology | 45 | 10% | 0% | 14 |
| 7 | Cell Biology | 5 | 5% | 0% | 7 |
| 8 | Microscopy | 5 | 1% | 0% | 1 |
| 9 | Biochemistry & Molecular Biology | 4 | 10% | 0% | 13 |
| 10 | Materials Science, Biomaterials | 1 | 1% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | UNIT 0018 5 | 470403 | 1% | 100% | 2 |
| 2 | ANALYT DEV N AMER | 235202 | 1% | 100% | 1 |
| 3 | DISCOVERY S TSUKUBA | 235202 | 1% | 100% | 1 |
| 4 | KIMMEL UROL CANC | 235202 | 1% | 100% | 1 |
| 5 | NEUROL IMAGING CORE | 235202 | 1% | 100% | 1 |
| 6 | SANBON HOSP GUNPO | 235202 | 1% | 100% | 1 |
| 7 | HEMATOL PHYSIOL BIOL CELLULAIRE | 192433 | 2% | 27% | 3 |
| 8 | MORFOL MOL PATHOL | 117600 | 1% | 50% | 1 |
| 9 | VET CANC | 117600 | 1% | 50% | 1 |
| 10 | GENITOURINARY MED ONCOL | 107034 | 14% | 2% | 19 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER GENE THERAPY | 17318 | 9% | 1% | 12 |
| 2 | JOURNAL OF UROLOGY | 6153 | 20% | 0% | 27 |
| 3 | GENE THERAPY | 2131 | 4% | 0% | 6 |
| 4 | HUMAN CELL | 1092 | 1% | 0% | 1 |
| 5 | UROLOGICAL RESEARCH | 1004 | 2% | 0% | 3 |
| 6 | CANCER BIOLOGY & THERAPY | 735 | 2% | 0% | 3 |
| 7 | CANCER BIOCHEMISTRY BIOPHYSICS | 639 | 1% | 0% | 1 |
| 8 | MOLECULAR THERAPY | 571 | 2% | 0% | 3 |
| 9 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 481 | 1% | 0% | 1 |
| 10 | PATHOGENS AND DISEASE | 449 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |